HuGE Literature Finder
Records 1-9
|
Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
Familial cancer 2019 Nov . Petry Vanessa, Bonadio Renata Colombo, Cagnacci Allyne Queiroz Carneiro, Senna Luiz Antonio Leite, Campos Roberta do Nascimento Galvão, Cotti Guilherme Cutait, Hoff Paulo M, Fragoso Maria Candida Barisson Villares, Estevez-Diz Maria Del Pil |
|
Genomic landscape of ductal carcinoma in situ and association with progression.
Breast cancer research and treatment 2019 Aug . Lin Chieh-Yu, Vennam Sujay, Purington Natasha, Lin Eric, Varma Sushama, Han Summer, Desa Manisha, Seto Tina, Wang Nicholas J, Stehr Henning, Troxell Megan L, Kurian Allison W, West Robert |
|
Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.
Virchows Archiv : an international journal of pathology 2019 Aug . Tsuyama Sho, Saito Tsuyoshi, Akazawa Yoichi, Yanai Yuka, Yatagai Noboru, Akaike Keisuke, Hayashi Takuo, Suehara Yoshiyuki, Takahashi Fumiyuki, Takamochi Kazuya, Hashimoto Takashi, Kajiyama Yoshiaki, Tsurumaru Masahiko, Fukunaga Tetsu, Yao Takas |
|
Comprehensive multigene mutation spectra of breast cancer patients from Northeast China obtained using the Ion Torrent sequencing platform.
Oncology reports 2019 Jul . Fan Chunni, Liu Ning, Fan Shulin, Yang Zhaoying, Ye Ning, Wang Ker |
|
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years.
Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
|
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Mar . Pang Jia-Min B, Savas Peter, Fellowes Andrew P, Mir Arnau Gisela, Kader Tanjina, Vedururu Ravikiran, Hewitt Chelsee, Takano Elena A, Byrne David J, Choong David Yh, Millar Ewan Ka, Lee C Soon, O'Toole Sandra A, Lakhani Sunil R, Cummings Margaret C, Mann G Bruce, Campbell Ian G, Dobrovic Alexander, Loi Sherene, Gorringe Kylie L, Fox Stephen |
|
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Oncotarget 2015 Apr 6 (10): 7597-607. Kim Shinn Young, Jung Seung-Hyun, Kim Min Sung, Baek In-Pyo, Lee Sung Hak, Kim Tae-Min, Chung Yeun-Jun, Lee Sug Hyu |
|
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.
Molecular oncology 2009 Jun 3 (3): 214-9. Zhou Wenjing, Muggerud Aslaug A, Vu Phuong, Due Eldri U, Sørlie Therese, Børresen-Dale Anne-Lise, Wärnberg Fredrik, Langerød Ani |
|
Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Carcinogenesis 2007 Aug 28 (8): 1680-6. Sprague Brian L, Trentham-Dietz Amy, Garcia-Closas Montserrat, Newcomb Polly A, Titus-Ernstoff Linda, Hampton John M, Chanock Stephen J, Haines Jonathan L, Egan Kathleen |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 05, 2021
- Content source: